FDA Clearance Tracker · P140002
MISAGO PERIPHERAL SELF-EXPANDING STENT SYSTEM
Last checked: Nov 20, 2026Latest source record: May 22, 2015 (this decision)Source: openFDAMethods & limitations
Decided
May 22, 2015
Approved
Time to decision
442 days
Received Mar 6, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P140002
- Device name
- MISAGO PERIPHERAL SELF-EXPANDING STENT SYSTEM
- Applicant
- Terumo Medical Corporation
- Applicant location
- Hatagaya
- Received
- Mar 6, 2014
- Decided
- May 22, 2015
- Decision
- Approved
- Supplements
- 31 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- STENT, SUPERFICIAL FEMORAL ARTERY (NIP)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE MISAGO PERIPHERAL SELF-EXPANDING STENT SYSTEM. THIS DEVICE IS INDICATED TO IMPROVE LUMINAL DIAMETER IN SYMPTOMATIC PATIENTS WITH DE NOVO OR RESTENOTIC NATIVE LESIONS OR OCCLUSIONS OF THE SUPERFICIAL FEMORAL ARTERY (SFA) AND/OR PROXIMAL POPLITEAL ARTERY WITH REFERENCE VESSEL DIAMETERS RANGING FROM 4MM TO 7MM AND LESION LENGTH UP TO 150MM.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NIP. The earliest in FDA's data is P000033, decided Apr 3, 2002.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Terumo Medical Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MISAGO(TM) RX Self-expanding Peripheral StentPMA supplement
P140002-S032 · Decided Jul 16, 2026 · 199 days after receipt · Panel Track
Device type: STENT, ILIAC (NIO) · Cardiology
P210017 · Decided Sep 26, 2023 · 880 days after receipt
Device type: Device, hemostasis, vascular (MGB) · Cardiology
- R2P Navicross510(k)
K231044 · Decided Jul 27, 2023 · 106 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.